Apolipoprotein E dysfunction in Alzheimer’s disease: a study on miRNA regulation, glial markers, and amyloid pathology
2024

Apolipoprotein E Dysfunction in Alzheimer's Disease: A Study on miRNA Regulation, Glial Markers, and Amyloid Pathology

Sample size: 26 publication 10 minutes Evidence: moderate

Author Information

Author(s): Wijesinghe Printha, Li Hao Ran, Ai Zhengyuan, Campbell Matthew, Chen Si Xuan, Xi Jeanne, Pham Wellington, Matsubara Joanne A.

Primary Institution: The University of British Columbia

Hypothesis

ApoE deficiency alters miRNA and mRNA expression levels, disrupts glial homeostasis and APP/Aβ peptide clearance.

Conclusion

The study highlights ApoE's critical role in Alzheimer's disease by demonstrating its impact on inflammatory and amyloidogenic miRNA expression, glial homeostasis, and APP/Aβ peptide clearance.

Supporting Evidence

  • MiRNA levels were lower in 3-month-old Apoe-ko mice but increased in 9-month-old mice across five brain regions.
  • A high-fat diet enhanced miRNA dysregulation in brain and eye tissues.
  • Elevated Gfap expression and increased APP/Aβ peptide accumulation were observed in 9-month-old Apoe-ko mice.

Takeaway

This study shows that a protein called ApoE is important for brain health, and when it doesn't work properly, it can lead to problems in Alzheimer's disease.

Methodology

The study compared female Apoe-ko mice on a regular diet to age-matched controls at 3 and 9 months, analyzing miRNAs, mRNAs, and protein markers.

Limitations

The study has a small sample size, focuses only on female mice, and analyzes only two time points.

Participant Demographics

All participants were female Apoe-ko mice.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fnagi.2024.1495615

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication